Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flu-M3: Kinetics of Immune Responses to Intranasal LAIV
NCT04110366Completed
- Sponsor
- Imperial College Healthcare NHS Trust
- Start
- Jun 2018
- Primary completion
- Apr 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label trial of live attenuated influenza vaccine in influenza (2 arms), sponsored by Imperial College Healthcare NHS Trust. Primary endpoints: Number of Participants Shedding Each Vaccine Virus and Nasal mucosal levels of IgA and IgG antibodies. Started Jun 2018; status: completed.
02
Drugs
live attenuated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT04110366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04110366.